Checkpoint Therapeutics Probability of Future Stock Price Finishing Over 5.01
| CKPTDelisted Stock | USD 4.26 0.02 0.47% |
Checkpoint |
Checkpoint Therapeutics Target Price Odds to finish over 5.01
The tendency of Checkpoint Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 5.01 or more in 90 days |
| 4.26 | 90 days | 5.01 | about 1.34 |
Based on a normal probability distribution, the odds of Checkpoint Therapeutics to move over $ 5.01 or more in 90 days from now is about 1.34 (This Checkpoint Therapeutics probability density function shows the probability of Checkpoint Stock to fall within a particular range of prices over 90 days) . Probability of Checkpoint Therapeutics price to stay between its current price of $ 4.26 and $ 5.01 at the end of the 90-day period is about 21.47 .
Given the investment horizon of 90 days the stock has the beta coefficient of 4.0 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Checkpoint Therapeutics will likely underperform. Additionally Checkpoint Therapeutics has an alpha of 0.4325, implying that it can generate a 0.43 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Checkpoint Therapeutics Price Density |
| Price |
Predictive Modules for Checkpoint Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Checkpoint Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Checkpoint Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Checkpoint Therapeutics is not an exception. The market had few large corrections towards the Checkpoint Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Checkpoint Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Checkpoint Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.43 | |
β | Beta against Dow Jones | 4.00 | |
σ | Overall volatility | 0.51 | |
Ir | Information ratio | 0.1 |
Checkpoint Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Checkpoint Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Checkpoint Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Checkpoint Therapeutics is not yet fully synchronised with the market data | |
| Checkpoint Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Checkpoint is showing solid risk-adjusted performance over 90 days | |
| The company reported the previous year's revenue of 41 K. Net Loss for the year was (56.24 M) with loss before overhead, payroll, taxes, and interest of (31.4 M). | |
| Checkpoint Therapeutics currently holds about 30.89 M in cash with (31.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33. | |
| Roughly 14.0% of the company shares are held by company insiders |
Checkpoint Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Checkpoint Stock often depends not only on the future outlook of the current and potential Checkpoint Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Checkpoint Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.7 M | |
| Cash And Short Term Investments | 6.6 M |
Checkpoint Therapeutics Technical Analysis
Checkpoint Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Checkpoint Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Checkpoint Therapeutics. In general, you should focus on analyzing Checkpoint Stock price patterns and their correlations with different microeconomic environments and drivers.
Checkpoint Therapeutics Predictive Forecast Models
Checkpoint Therapeutics' time-series forecasting models is one of many Checkpoint Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Checkpoint Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Checkpoint Therapeutics
Checking the ongoing alerts about Checkpoint Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Checkpoint Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Checkpoint Therapeutics is not yet fully synchronised with the market data | |
| Checkpoint Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Checkpoint is showing solid risk-adjusted performance over 90 days | |
| The company reported the previous year's revenue of 41 K. Net Loss for the year was (56.24 M) with loss before overhead, payroll, taxes, and interest of (31.4 M). | |
| Checkpoint Therapeutics currently holds about 30.89 M in cash with (31.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33. | |
| Roughly 14.0% of the company shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Checkpoint Stock
If you are still planning to invest in Checkpoint Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Checkpoint Therapeutics' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |